Valeria.Panebianco@uniroma1.it's picture

CORSO DI LAUREA "A" - DIAGNOSTICA PER IMMAGINI: 

- Orario Lezioni: https://corsidilaurea.uniroma1.it/it/corso/2020/30891/programmazione

- Link di accesso: https://corsidilaurea.uniroma1.it/it/node/2452830

 

CORSO DI LAUREA "F" - DIAGNOSTIC IMAGING:

Cari Studenti,

tutte le lezioni e le notizie relative alla didattica sono sempre condivise sulla piattaforma moodle dei vari moduli in cui insegno (https://elearning.uniroma1.it/).
Le lezioni, in questo periodo , sono svolte in modalità "blended" (in presenza e a distanza) in maniera sincrona utilizzando la piattaforma ZOOM o MEET a seconda delle modalità concordate nei vari Corsi di Laurea in cui insegno, seguendo il calendario delle lezioni fornito dal Corso di Laurea.

 

Dear students,

All lessons and news related to the teaching activities are always shared on the moodle platform of the various modules I teach in (https://elearning.uniroma1.it/).

The lessons, in this period, are carried out in blended mode (with students in the classroom and online) using the ZOOM or MEET platform according to the methods agreed on in the various Degree Courses. The lessons take place following the schedules of lessons provided by the Degree Courses.

Course Code Year Course - Attendance Bulletin board
ADE AAF1433 2023/2024
APPARECCHIATURE DELL'AREA RADIOLOGICA 1052076 2023/2024
TIROCINIO PRATICO VALUTATIVO PER L'ESAME DI STATO - AREA CHIRURGICA TPVES101 2023/2024
DIAGNOSTICA PER IMMAGINI 10596539 2023/2024
DIAGNOSTIC IMAGING 1038250 2023/2024
MEDICINA INTERNA E CHIRURGIA GENERALE II 1023933 2023/2024
MEDICINA INTERNA E CHIRURGIA GENERALE II 10596556 2023/2024
ADE AAF1433 2022/2023
TIROCINIO PRATICO VALUTATIVO PER L'ESAME DI STATO - AREA CHIRURGICA TPVES101 2022/2023
DIAGNOSTICA PER IMMAGINI 10596539 2022/2023
DIAGNOSTIC IMAGING 1038250 2022/2023
APPARECCHIATURE DELL'AREA RADIOLOGICA 1052076 2022/2023
MEDICINA INTERNA E CHIRURGIA GENERALE II 1023933 2022/2023
DIAGNOSTICA PER IMMAGINI 1025577 2022/2023
DIAGNOSTIC IMAGING 1038250 2022/2023
MEDICINA INTERNA E CHIRURGIA GENERALE II 10596556 2022/2023
ADE AAF1433 2021/2022
TIROCINIO PRATICO VALUTATIVO PER L'ESAME DI STATO - AREA CHIRURGICA TPVES101 2021/2022
APPARECCHIATURE DELL'AREA RADIOLOGICA 1052076 2021/2022
DIAGNOSTICA PER IMMAGINI 10596539 2021/2022
DIAGNOSTICA PER IMMAGINI 1025577 2021/2022
MEDICINA INTERNA E CHIRURGIA GENERALE II 1023933 2021/2022
DIAGNOSTIC IMAGING 1038250 2021/2022
DIAGNOSTIC IMAGING 1038250 2021/2022
MEDICINA INTERNA E CHIRURGIA GENERALE II 10596556 2021/2022
ADE AAF1433 2020/2021
TIROCINIO PRATICO VALUTATIVO PER L'ESAME DI STATO - AREA CHIRURGICA TPVES101 2020/2021
APPARECCHIATURE DELL'AREA RADIOLOGICA 1052076 2020/2021
MEDICINA INTERNA E CHIRURGIA GENERALE II 1023933 2020/2021
DIAGNOSTICA PER IMMAGINI 10596539 2020/2021
DIAGNOSTIC IMAGING 1038250 2020/2021
DIAGNOSTICA PER IMMAGINI 1025577 2020/2021
MEDICINA INTERNA E CHIRURGIA GENERALE II 10596556 2020/2021
DIAGNOSTIC IMAGING 1038250 2020/2021
ADE AAF1433 2019/2020
APPARECCHIATURE DELL'AREA RADIOLOGICA 1052076 2019/2020
DIAGNOSTICA PER IMMAGINI 1025577 2019/2020
CORSO INTERDISCIPLINARE I 1036306 2018/2019
CORSO INTERDISCIPLINARE I 1036306 2017/2018
CORSO INTERDISCIPLINARE I 1036306 2016/2017
CORSO INTERDISCIPLINARE I 1036306 2016/2017

Martedì, fascia orario 10-12
Per un'ottimizzazione dell'agenda degli appuntamenti è bene inviare prima un' e-mail all'indirizzo: valeria.panebianco@uniroma1.it

Tuesday, time slot 10-12
Please send first an e-mail for the optimization of the appointments' agenda to the email address: valeria.panebianco@uniroma1.it

CV

PERSONAL INFORMATION Valeria Panebianco

E-mail address: valeria.panebianco@uniroma1.it
WORK EXPERIENCE

09/2019 Present Associate Professor of Radiology at Department of Radiological Sciences, Oncology & Pathology
Sapienza University of Rome, Rome (Italy)
Qualified to Full professor of Radiology ASN 2016
Responsible, Advanced MR & CT Imaging Division at U.O.C. of Radiology (Dir. Prof. C. Catalano) Coordinator, Prostate Unit

2002 2019 Specialist Radiologist
Department of Radiology at Department of Radiological Sciences, Oncology & Pathology, Policlinico Umberto I, Rome (Italy)

1999 2002 Specialist Radiologist
Department of Emergency, Policlinico Umberto I, Rome (Italy)

EDUCATION AND TRAINING

2003 2007 Residency in Nuclear Medicine EQF level8
Sapienza University of Rome, Rome (Italy)

1998 2002 Volunteer Assistant
Department of Radiology at Department of Radiological Sciences, Oncology & Pathology, Policlinico Umberto I, Rome (Italy)
Reasearch in urogenital and abdominal CT scan - MRI

1994 1998 Residency in Diagnostic Imaging & Images Sciences
Sapienza Unviersity of Rome, Rome (Italy) EQF level 8

1988 1993 Degree in Medicine and Surgery
Sapienza University of Rome, Rome (Italy)
EQF level 7

Scientific Profile
Valeria Panebianco has focused her research on precise approaches applied to prostate cancer for more than 10 years. VP s research has a special interest in
the application of computational medicine for the identification of prostate cancer with MRI and molecular biomarkers and in the definition of decisional algorithms for prostate cancer early detection. In this scenario, VP authored about 200 printed papers on peer reviewed journal, with participation, as leader of the Italian research group, to one of the largest randomized controlled trials for targeted prostate biopsy role in prostate cancer diagnosis, the PRECISION trial; the results were published in 2018 in the New England Journal of Medicine(https://pubmed.ncbi.nlm.nih.gov/29552975/).
Recently, VP has organized the first Italian screening trial for the early detection of prostate cancer Prostate Cancer Secondary Screening in Sapienza -, PROSA (ClinicalTrials.gov Identifier: NCT04803188). Also, she has been the leader of a position papers on MRI standardization for Bladder Cancer (VI-RADS Vesical Imaging
Reporting and Data System) and on MRI standardization for Prostate Cancer Recurrence (PI-RR Prostate MRIfor local Recurrence Reporting)andhas beentheco-authorof many
position papers on prostate cancer management and the application of computation tools to its diagnostic pathway. She has been appointed by the World Health Organization(WHO) to take part to the drafting of the WHO blue book on Urinary Tumors. Since 2022, VP took part to the panel of experts who delineated the latest version of EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer (EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. ISBN 978-94-92671-16-5). In 2022, VP participated to the PI-CAI Challenge on Artificial Intelligence for Prostate Cancer Detection in MRI as member of the Scientific Advisory Board.

PERSONAL SKILLS

Mother tongue Italian,
Additional language English

ADDITIONAL INFORMATION

National and International
Appointments

2020-Today: Faculty Member, PhD on Network Oncology and Precision Medicine
2019-Today: ACR international representative, PI-RADS (Prostate Imaging Reporting and Data System) Committee of American College of Radiology /ACR).
2019-Today: Member, Committee of the STITCH (Sapienza information-based Technology InnovaTion Center for Health)
2017-Today: Faculty Member and Promotor, EAU (European Association of Urology) / ESU (European Schoolof Urology) MRI Masterclass in Prostatecancer.
2016-Today: Member and Reviser, ACI (Accreditation Council in Imaging) Reviewing Committee, EBR (European Board of Radiology).
2014-Today: Member, Genitourinary Scientific Sub-Committee of the ECR (European Congress of Radiology)
2011-Today: Faculty Member and Promoter, ESUR (European Society of Urogenital Radiology) Teaching Courses on Prostate MRI.
2010-Today: Faculty Member and Member of the working group on prostate cancer, ESUR (European Society of Urogenital Radiology)
2015-2018: President, Italian Chapter dell ISMRM (International Society of Magnetic Resonance in Medicine).
2014-2018: Member, AMPC (Annual Meeting Program Committee); ISMRM (International Society of Magnetic Resonance in Medicine).

Scientific Activity
Author of:
- 212 printed papers on "peer-reviewed journals
- 42 Books(Chapters)
- 5 Books(Monographs)

- Impact Factor: 43.21
- H-Index: 39

Area of Research:
- Urogenital imaging focused on MRI of the prostate gland and the urinary bladder
- Computed Tomography, single-slice and multi-slice spiral CT (kidneys, virtoscopy); image post- processing.

Scientific Papers
Most recent 40 publications:

1: Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, Kassouf W,
Mitchell T, Montironi R, O'Brien T, Panebianco V, Scelo G, Shuch B, van Poppel
H, Blosser CD, Psutka SP. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur
Urol. 2022 Nov;82(5):529-542. doi: 10.1016/j.eururo.2022.08.019. Epub 2022 Sep
10. PMID: 36100483.

2: Panebianco V, Villeirs G, Weinreb JC, Turkbey BI, Margolis DJ, Richenberg J,
Schoots IG, Moore CM, Futterer J, Macura KJ, Oto A, Bittencourt LK, Haider MA,
Salomon G, Tempany CM, Padhani AR, Barentsz JO. Prostate Magnetic Resonance
Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based
Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer
Recurrence after Radiation Therapy and Radical Prostatectomy. Eur Urol Oncol.
2021 Dec;4(6):868-876. doi: 10.1016/j.euo.2021.01.003. Epub 2021 Feb 10. PMID:
33582104.

3: Hensley PJ, Panebianco V, Pietzak E, Kutikov A, Vikram R, Galsky MD, Shariat
SF, Roupret M, Kamat AM. Contemporary Staging for Muscle-Invasive Bladder
Cancer: Accuracy and Limitations. Eur Urol Oncol. 2022 Aug;5(4):403-411. doi:
10.1016/j.euo.2022.04.008. Epub 2022 May 14. PMID: 35581143.

4: Messina E, Pisciotti ML, Pecoraro M, Borrelli A, Del Giudice F, Panebianco V.
The use of MRI in urothelial carcinoma. Curr Opin Urol. 2022 Sep
1;32(5):536-544. doi: 10.1097/MOU.0000000000001011. Epub 2022 Jul 15. PMID:
35849696.

5: Nicola R, Pecoraro M, Lucciola S, Dos Reis RB, Narumi Y, Panebianco V, Muglia
VF. VI-RADS score system - A primer for urologists. Int Braz J Urol. 2022 Jul-
Aug;48(4):609-622. doi: 10.1590/S1677-5538.IBJU.2021.0560. PMID: 35195385;
PMCID: PMC9306377.

6: Panebianco V, Pecoraro M, Del Giudice F, Takeuchi M, Muglia VF, Messina E,
Cipollari S, Giannarini G, Catalano C, Narumi Y. VI-RADS for Bladder Cancer:
Current Applications and Future Developments. J Magn Reson Imaging. 2022
Jan;55(1):23-36. doi: 10.1002/jmri.27361. Epub 2020 Sep 17. PMID: 32939939.

7: Pecoraro M, Messina E, Bicchetti M, Carnicelli G, Del Monte M, Iorio B, La
Torre G, Catalano C, Panebianco V. The future direction of imaging in prostate
cancer: MRI with or without contrast injection. Andrology. 2021
Sep;9(5):1429-1443. doi: 10.1111/andr.13041. Epub 2021 Jun 8. PMID: 33998173.

8: Messina E, Pecoraro M, Pisciotti ML, Del Giudice F, Lucciola S, Bicchetti M,
Laschena L, Roberto M, De Berardinis E, Franco G, Panebianco V. Seeing is
Believing: State of the Art Imaging of Bladder Cancer. Semin Radiat Oncol. 2023
Jan;33(1):12-20. doi: 10.1016/j.semradonc.2022.10.002. PMID: 36517189.

9: Del Giudice F, Flammia RS, Pecoraro M, Moschini M, D'Andrea D, Messina E,
Pisciotti LM, De Berardinis E, Sciarra A, Panebianco V. The accuracy of Vesical
Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-
institutional, multi-readers systematic review and meta-analysis from diagnostic
evidence into future clinical recommendations. World J Urol. 2022
Jul;40(7):1617-1628. doi: 10.1007/s00345-022-03969-6. Epub 2022 Mar 16. PMID:
35294583; PMCID: PMC9237003.

10: Schoots IG, Barentsz JO, Bittencourt LK, Haider MA, Macura KJ, Margolis DJA,
Moore CM, Oto A, Panebianco V, Siddiqui MM, Tempany C, Turkbey B, Villeirs GM,
Weinreb JC, Padhani AR. PI-RADS Committee Position on MRI Without Contrast
Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative Review. AJR
Am J Roentgenol. 2021 Jan;216(1):3-19. doi: 10.2214/AJR.20.24268. Epub 2020 Nov
19. PMID: 32812795.

11: Giganti F, Panebianco V, Tempany CM, Purysko AS. Is Artificial Intelligence
Replacing Our Radiology Stars in Prostate Magnetic Resonance Imaging? The Stars
Do Not Look Big, But They Can Look Brighter. Eur Urol Open Sci. 2022 Dec
16;48:12-13. doi: 10.1016/j.euros.2022.11.021. PMID: 36578461; PMCID:
PMC9791603.

12: Panebianco V, Turkbey B. Magnetic resonance imaging for prostate cancer
recurrence: it's time for precision diagnostic with Prostate Imaging for
Recurrence Reporting (PI-RR) score. Eur Radiol. 2023 Feb;33(2):748-751. doi:
10.1007/s00330-022-09095-6. Epub 2022 Sep 1. PMID: 36048204.

13: Pecoraro M, Turkbey B, Purysko AS, Girometti R, Giannarini G, Villeirs G,
Roberto M, Catalano C, Padhani AR, Barentsz JO, Panebianco V. Diagnostic
Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence
Reporting Assessment Score. Radiology. 2022 Aug;304(2):342-350. doi:
10.1148/radiol.212252. Epub 2022 May 10. PMID: 35536130.

14: Girometti R, Giannarini G, Panebianco V, Maresca S, Cereser L, De Martino M,
Pizzolitto S, Pecoraro M, Ficarra V, Zuiani C, Valotto C. Comparison of
different thresholds of PSA density for risk stratification of PI-RADSv2.1
categories on prostate MRI. Br J Radiol. 2022 Mar 1;95(1131):20210886. doi:
10.1259/bjr.20210886. Epub 2021 Nov 11. PMID: 34762506; PMCID: PMC8978227.

15: da Silva MC, Pecoraro M, Pisciotti ML, Dehghanpour A, Forookhi A, Lucciola
S, Bicchetti M, Messina E, Catalano C, Panebianco V. The learning curve in
bladder MRI using VI-RADS assessment score during an interactive dedicated
training program. Eur Radiol. 2022 Nov;32(11):7494-7503. doi:
10.1007/s00330-022-08766-8. Epub 2022 Apr 2. PMID: 35366122; PMCID: PMC8976109.

16: Cipollari S, Guarrasi V, Pecoraro M, Bicchetti M, Messina E, Farina L, Paci
P, Catalano C, Panebianco V. Convolutional Neural Networks for Automated
Classification of Prostate Multiparametric Magnetic Resonance Imaging Based on
Image Quality. J Magn Reson Imaging. 2022 Feb;55(2):480-490. doi:
10.1002/jmri.27879. Epub 2021 Aug 9. PMID: 34374181; PMCID: PMC9291235.

17: Pecoraro M, Del Giudice F, Magliocca F, Simone G, Flammia S, Leonardo C,
Messina E, De Berardinis E, Cortesi E, Panebianco V. Vesical Imaging-Reporting
and Data System (VI-RADS) for assessment of response to systemic therapy for
bladder cancer: preliminary report. Abdom Radiol (NY). 2022 Feb;47(2):763-770.
doi: 10.1007/s00261-021-03365-5. Epub 2021 Dec 17. PMID: 34919160.

18: Cipollari S, Pecoraro M, Forookhi A, Laschena L, Bicchetti M, Messina E,
Lucciola S, Catalano C, Panebianco V. Biparametric prostate MRI: impact of a
deep learning-based software and of quantitative ADC values on the inter-reader
agreement of experienced and inexperienced readers. Radiol Med. 2022
Nov;127(11):1245-1253. doi: 10.1007/s11547-022-01555-9. Epub 2022 Sep 17. PMID:
36114928; PMCID: PMC9587977.

19: Bicchetti M, Simone G, Giannarini G, Girometti R, Briganti A, Brunocilla E,
Cardone G, De Cobelli F, Gaudiano C, Del Giudice F, Flammia S, Leonardo C,
Pecoraro M, Schiavina R, Catalano C, Panebianco V. A novel pathway to detect
muscle-invasive bladder cancer based on integrated clinical features and VI-RADS
score on MRI: results of a prospective multicenter study. Radiol Med. 2022
Aug;127(8):881-890. doi: 10.1007/s11547-022-01513-5. Epub 2022 Jun 28. PMID:
35763251; PMCID: PMC9349064.

20: Del Giudice F, van Uem S, Li S, Vilson FL, Sciarra A, Salciccia S, Busetto
GM, Maggi M, Tiberia L, Viscuso P, Canale V, Panebianco V, Pecoraro M, Ferro M,
Moschini M, Krajewski W, D'Andrea D, Cacciamani GE, Mari A, Soria F, Porpiglia
F, Fiori C, Amparore D, Checcucci E, Autorino R, De Berardinis E, Chung BI.
Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical
Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing
Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on
Perioperative Outcomes and Health Care Costs. Clin Genitourin Cancer. 2022
Apr;20(2):198.e1-198.e9. doi: 10.1016/j.clgc.2021.11.016. Epub 2021 Dec 24.
PMID: 35031226.

21: Lucciola S, Pisciotti ML, Frisenda M, Magliocca F, Gentilucci A, Del Giudice
F, Canale V, Scarrone E, Busetto GM, Carrieri G, Cormio L, Carbone A, Pastore A,
De Nunzio C, Tubaro A, Leonardo C, Franco G, Di Pierro GB, Salciccia S, Sciarra
A, Panebianco V. Predictive role of node-rads score in patients with prostate
cancer candidates for radical prostatectomy with extended lymph node dissection:
comparative analysis with validated nomograms. Prostate Cancer Prostatic Dis.
2022 Jun 22. doi: 10.1038/s41391-022-00564-z. Epub ahead of print. PMID:
35732820.

22: Del Monte M, Cipollari S, Del Giudice F, Pecoraro M, Bicchetti M, Messina E,
Dehghanpour A, Ciardi A, Sciarra A, Catalano C, Panebianco V. MRI-directed
biopsy for primary detection of prostate cancer in a population of 223 men: MRI
In-Bore vs MRI-transrectal ultrasound fusion-targeted techniques. Br J Radiol.
2022 Mar 1;95(1131):20210528. doi: 10.1259/bjr.20210528. Epub 2021 Oct 5. PMID:
34609900; PMCID: PMC8978234.

23: Sciarra A, Maggi M, Del Proposto A, Magliocca FM, Ciardi A, Panebianco V, De
Berardinis E, Salciccia S, Di Pierro GB, Gentilucci A, Kasman AM, Chung BI,
Ferro M, de Cobelli O, Del Giudice F, Busetto GM, Gallucci M, Frisenda M. Impact
of uni- or multifocal perineural invasion in prostate cancer at radical
prostatectomy. Transl Androl Urol. 2021 Jan;10(1):66-76. doi:
10.21037/tau-20-850. PMID: 33532297; PMCID: PMC7844528.

24: Kasivisvanathan V, Chan VW, Clement KD, Levis B, Haider M, Agarwal R,
Emberton M, Pond GR, Takwoingi Y, Klotz L, Moore CM; VISION study collaborators.
A protocol for the VISION study: An indiVidual patient data meta-analysis of
randomised trials comparing MRI-targeted biopsy to standard transrectal
ultraSound guided bIopsy in the detection of prOstate cancer. PLoS One. 2022 Feb
3;17(2):e0263345. doi: 10.1371/journal.pone.0263345. PMID: 35113918; PMCID:
PMC8812968.

25: Galea N, Catapano F, Marchitelli L, Cundari G, Maestrini V, Panebianco V,
Mancone M, Fedele F, Catalano C, Francone M. How to perform a cardio-thoracic
magnetic resonance imaging in COVID-19: comprehensive assessment of heart,
pulmonary arteries, and lung parenchyma. Eur Heart J Cardiovasc Imaging. 2021
Jun 22;22(7):728-731. doi: 10.1093/ehjci/jeaa335. PMID: 33325495; PMCID:
PMC7799188.

26: Pecoraro M, Panebianco V. Multiparametric Prostate MRI for Biochemical
Failure in the Era of Targeted PET Radiotracers: Counterpoint-MRI Remains a
Specific and Accessible Test for Targeted Management. AJR Am J Roentgenol. 2023
Feb;220(2):188-189. doi: 10.2214/AJR.22.28042. Epub 2022 Jun 1. PMID: 35642757.

27: Panebianco V, Del Giudice F, Narumi Y, Simone G, De Berardinis E, Catto JWF.
Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the
Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea
Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic
Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant
Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the
PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI
Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol
2021;79:e35-e36. Eur Urol. 2021 Feb;79(2):e52-e53. doi:
10.1016/j.eururo.2020.11.003. Epub 2020 Nov 28. PMID: 33261940.

28: Pecoraro M, Cipollari S, Marchitelli L, Messina E, Del Monte M, Galea N,
Ciardi MR, Francone M, Catalano C, Panebianco V. Cross-sectional analysis of
follow-up chest MRI and chest CT scans in patients previously affected by
COVID-19. Radiol Med. 2021 Oct;126(10):1273-1281. doi:
10.1007/s11547-021-01390-4. Epub 2021 Jul 12. PMID: 34251585; PMCID: PMC8274263.

29: Penzkofer T, Padhani AR, Turkbey B, Haider MA, Huisman H, Walz J, Salomon G,
Schoots IG, Richenberg J, Villeirs G, Panebianco V, Rouviere O, Logager VB,
Barentsz J. ESUR/ESUI position paper: developing artificial intelligence for
precision diagnosis of prostate cancer using magnetic resonance imaging. Eur
Radiol. 2021 Dec;31(12):9567-9578. doi: 10.1007/s00330-021-08021-6. Epub 2021
May 15. PMID: 33991226; PMCID: PMC8589789.

30: Lai S, Perrotta AM, Panebianco V, Mazzaferro S, Menè P, Pellicano C, Tinti
F, Muscaritoli M, Cianci R, Gigante A. Parasympathetic activity and total
fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a
pilot study. Int Urol Nephrol. 2023 Apr 12. doi: 10.1007/s11255-023-03551-y.
Epub ahead of print. PMID: 37043156.

31: Jakobsen JÅ, Quattrocchi CC, Müller FHH, Outteryck O, Alcázar A, Reith W,
Fraga P, Panebianco V, Sampedro A, Pietura R. Patterns of use, effectiveness and
safety of gadolinium contrast agents: a European prospective cross-sectional
multicentre observational study. BMC Med Imaging. 2021 Apr 20;21(1):74. doi:
10.1186/s12880-021-00600-9. PMID: 33879075; PMCID: PMC8056663.

32: Schiavina R, Droghetti M, Novara G, Bianchi L, Gaudiano C, Panebianco V,
Borghesi M, Piazza P, Mineo Bianchi F, Guerra M, Corcioni B, Fiorentino M,
Giunchi F, Verze P, Pultrone C, Golfieri R, Porreca A, Mirone V, Brunocilla E.
The role of multiparametric MRI in active surveillance for low-risk prostate
cancer: The ROMAS randomized controlled trial. Urol Oncol. 2021
Jul;39(7):433.e1-433.e7. doi: 10.1016/j.urolonc.2020.10.018. Epub 2020 Nov 13.
PMID: 33191117.

33: Masci GM, Iafrate F, Ciccarelli F, Pambianchi G, Panebianco V, Pasculli P,
Ciardi MR, Mastroianni CM, Ricci P, Catalano C, Francone M. Tocilizumab effects
in COVID-19 pneumonia: role of CT texture analysis in quantitative assessment of
response to therapy. Radiol Med. 2021 Sep;126(9):1170-1180. doi:
10.1007/s11547-021-01371-7. Epub 2021 Jun 5. PMID: 34089436; PMCID: PMC8178666.

34: Wibmer AG, Kattan MW, Alessandrino F, Baur ADJ, Boesen L, Franco FB,
Bonekamp D, Campa R, Cash H, Catalá V, Crouzet S, Dinnoo S, Eastham J, Fennessy
FM, Ghabili K, Hohenfellner M, Levi AW, Ji X, Løgager V, Margolis DJ, Moldovan
PC, Panebianco V, Penzkofer T, Puech P, Radtke JP, Rouvière O, Schlemmer HP,
Sprenkle PC, Tempany CM, Vilanova JC, Weinreb J, Hricak H, Shukla-Dave A.
International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for
Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer. Cancers
(Basel). 2021 May 27;13(11):2627. doi: 10.3390/cancers13112627. PMID: 34071842;
PMCID: PMC8198352.

35: Giganti F, Stabile A, Stavrinides V, Osinibi E, Retter A, Orczyk C,
Panebianco V, Trock BJ, Freeman A, Haider A, Punwani S, Allen C, Kirkham A,
Emberton M, Moore CM. Natural history of prostate cancer on active surveillance:
stratification by MRI using the PRECISE recommendations in a UK cohort. Eur
Radiol. 2021 Mar;31(3):1644-1655. doi: 10.1007/s00330-020-07256-z. Epub 2020 Sep
30. PMID: 33000302; PMCID: PMC7880925.

36: Sciarra A, Frisenda M, Maggi M, Magliocca FM, Ciardi A, Panebianco V,
Berardinis E, Salciccia S, Di Pierro GB, Gentilucci A, Del Giudice F, Busetto
GM, Tufano A. Prospective comparative trial on nerve-sparing radical
prostatectomy using a robot-assisted versus laparoscopic technique: expectation
versus satisfaction and impact on surgical margins. Cent European J Urol.
2021;74(2):169-177. doi: 10.5173/ceju.2021.0017.R3. Epub 2021 May 7. PMID:
34336234; PMCID: PMC8318028.

37: Salciccia S, Rosati D, Viscuso P, Canale V, Scarrone E, Frisenda M, Catuzzi
R, Moriconi M, Asero V, Signore S, De Dominicis M, Emiliozzi P, Carbone A,
Pastore AL, Fuschi A, Di Pierro GB, Gentilucci A, Cattarino S, Mariotti G,
Busetto GM, Ferro M, De Berardinis E, Ricciuti GP, Panebianco V, Magliocca FM,
Del Giudice F, Maggi M, Sciarra A. Influence of operative time and blood loss on
surgical margins and functional outcomes for laparoscopic versus robotic-
assisted radical prostatectomy: a prospective analysis. Cent European J Urol.
2021;74(4):503-515. doi: 10.5173/ceju.2021.0177. Epub 2021 Nov 29. PMID:
35083069; PMCID: PMC8771133.

38: Panebianco V, Paci P, Pecoraro M, Conte F, Carnicelli G, Besharat ZM,
Catanzaro G, Splendiani E, Sciarra A, Farina L, Catalano C, Ferretti E. Network
Analysis Integrating microRNA Expression Profiling with MRI Biomarkers and
Clinical Data for Prostate Cancer Early Detection: A Proof of Concept Study.
Biomedicines. 2021 Oct 14;9(10):1470. doi: 10.3390/biomedicines9101470. PMID:
34680592; PMCID: PMC8533640.

39: Leonardo C, Flammia RS, Lucciola S, Proietti F, Pecoraro M, Bucca B, Licari
LC, Borrelli A, Bologna E, Landini N, Del Monte M, Chung BI, Catalano C,
Magliocca FM, De Berardinis E, Del Giudice F, Panebianco V. Performance of Node-
RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in
Bladder Cancer Patients. Cancers (Basel). 2023 Jan 18;15(3):580. doi:
10.3390/cancers15030580. PMID: 36765540; PMCID: PMC9913205.

40: Messina E, Pecoraro M, Laschena L, Bicchetti M, Proietti F, Ciardi A,
Leonardo C, Sciarra A, Girometti R, Catalano C, Panebianco V. Low cancer yield
in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: is it time to
reconsider scoring categorization? Eur Radiol. 2023 Apr 13. doi:
10.1007/s00330-023-09605-0. Epub ahead of print. PMID: 37045981.

41. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budäus L,
Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G,
Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C,
Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM;
PRECISION Study Group Collaborators. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med.
2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993. Epub 2018 Mar 18. PMID: 29552975; PMCID: PMC9084630.

Society Membership

2017-Today: European Society of Oncologic Imaging (ESOI) 2017-Today: International Cancer Imaging Society (ICIS)
2014-Today: International Society of Magnetic Resonance in Medicine (ISMRM) 2010-Today: Italian Chapter dell International Society of MR in Medicine (ISMRM) 2009-Today: European Society of Urogenital radiology (ESUR)
2000-Today: Radiological Society of North America (RSNA)
1995-Today: European Society of Radiology (ESR) - European Congress of Radiology (ECR) 1994-Today: Società Italiana di Radiologia Medica (SIRM)

Awards and Honors

2017: Honorary Membership of the Accademia Medica di Roma
2011: Award best presentation Members's day "3T DTI Fiber tracking in the depiction of perirprostatic nerve before and after nerve-sparing prostatectomy", 18th Annual Symposium ESUR
2009: Award best presentation Members's day "Comparison and correlation between1H-MRI in vivo prostate spectrosocpy at 1.5T and ex-vivo high resolution magic angle 1H-NMR Spectroscopy at 11T in the evaluation of new metabolite levels in prostate cancer", 16th European Symposium on Urogenital Radiology ESUR
2005: "Cum Laude" Award for the original research "Functional MRI of esophagus in healthy subjects: evaluation of normal patterns and future prospects" RSNA
2005: Best presentation Award on "Elaborazioni 3D", Convegno Nazionale della sezione di Radiologia Informatica, Verona 2005: